Clifford Chance advised Pfizer on the sale of its plant in Illertissen to R-Pharm Group
Clifford Chance has advised Pfizer on the sale of its plant in Illertissen (Germany) to the Russian based R-Pharm Group. Pfizer and R-Pharm have also entered into a long-term contract regarding the continued manufacture of a number of Pfizer products by R-Pharm at the production site.
Pfizer employs in Illertissen about 400 employees, which is an highly automated facility using state of the art technologies.
The completion of the transaction is subject to several conditions precedent. Specific terms of the agreement, including price are confidential.